Pharmaceutical Technology20d
BioGam by Microgen for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura): Likelihood of Approval
BioGam is under clinical development by Microgen and currently in Phase III for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). According to GlobalData, Phase III drugs for ...
Sky News Australia29d
‘Senile’ Joe Biden claims Kamala Harris would’ve beaten Trump in an election
Social media users have roasted US President Joe Biden following a recent claim he made about Kamala Harris and Donald Trump. On Friday, the oldest-ever sitting president held a press conference ...
Pharmaceutical Technology1mon
RAY-121 by Chugai Pharmaceutical for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura): Likelihood of Approval
RAY-121 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). According to GlobalData, Phase I ...